CIK 0001582313 · Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- EIN
- 980661854
- Phone
- (604) 484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-18 | AULIN SHERRY Chief Financial Officer | Option exercise | +16,000 | $11.58 | $185K | 16,000 |
| 2024-12-18 | AULIN SHERRY Chief Financial Officer | Shares withheld for taxes | −4,490 | $41.28 | $185K | 11,510 |
| 2024-12-18 | AULIN SHERRY Chief Financial Officer | Sale | −11,510 | $41.19 | $474K | 0 |
| 2024-12-18 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,334 | 0 | ||
| 2024-12-18 | AULIN SHERRY Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −16,000 | 6,000 | ||
| 2024-11-22 | PATOU GARY Director | Option exercise | +3,500 | $7.38 | $26K | 27,073 |
| 2024-11-22 | PATOU GARY Director | Shares withheld for taxes | −649 | $39.80 | $26K | 26,424 |
| 2024-11-22 | PATOU GARY Director | Sale | −2,851 | $41.11 | $117K | 23,573 |
| 2024-11-22 | PATOU GARY Director | Option exercise | +3,086 | $13.48 | $42K | 26,659 |
| 2024-11-22 | PATOU GARY Director | Shares withheld for taxes | −1,046 | $39.80 | $42K | 25,613 |
| 2024-11-22 | PATOU GARY Director | Sale | −2,040 | $41.05 | $84K | 23,573 |
| 2024-11-22 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −3,500 | 0 | ||
| 2024-11-22 | PATOU GARY Director | Option exercise · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2024-06-05 | PATOU GARY Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | Gover Justin D. Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | GAROFALO ELIZABETH A. Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | Cannon Gillian Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-06-05 | Svoronos Dawn Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 |
Page 8 of 16 · 308 trades